# Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders

> **NCT00895271** · — · ENROLLING_BY_INVITATION · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 200 (estimated)

## Conditions studied

- Primary Immunodeficiency
- DOCK8
- Virus Susceptibility

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00895271
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2009-06-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00895271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00895271, "Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00895271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*